Cevper Ersoz

Cevper Ersoz

Auto-generated profile, based on publicly available information

Cevper Ersoz

Department of Urology, Faculty of Medicine, Bezmialem Vakıf University, İstanbul, Turkey

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Journal of Endourology
Verified
Journal Article
Closed access
ATAbdulkadir Tepeler
Abdulkadir Tepeler
AAAbdullah Armagan
Abdullah Armagan
ASAhmet Ali Sancaktutar
Ahmet Ali Sancaktutar
MSMesrur Selcuk Silay
Mesrur Selcuk Silay
NPNecmettin Penbegul
Necmettin Penbegul
MAMuzaffer Akcay
Muzaffer Akcay
Background and Purpose: The treatment of symptomatic lower pole (LP) calculi poses a challenge because of lower clearance rates. We present our experience with microperc in the treatment of LP renal calculi. Patients and Methods: We retrospectively evaluated the symptomatic patients with LP renal calculi who underwent microperc between August 2011 and June 2012 from two referral hospitals. Patients were included only in cases of failure after shockwave lithotripsy (SWL) or retrograde intrarenal surgery (RIRS) and according to patient preference. The percutaneous renal access was performed using the 4.8F “all-seeing needle” with C-arm fluoroscopy or ultrasonographic guidance with the patient in the prone position. Stone disintegration was established using a 200 μm holmium:yttrium-aluminum-garnet laser fiber. Results: A total of 21 patients (mean age 37.3±20.1 years) with LP stone underwent microperc. The mean body mass index was 28.6±6.0 kg/m2, and the mean stone size was 17.8±5.9 (9–29) mm. The duration of surgery and fluoroscopic screening was 62.8±25.2 minutes and 150.5±92.8 seconds, respectively. The patients were discharged after a mean 37.5±14.4 hours of hospitalization time. The mean hemoglobin drop was 0.8±0.6 (0.1–2.3) g/dL. Conversion to miniperc was necessitated in one patient with loss of vision. Stone-free status was achieved in 18 (85.7%) patients. Clinically insignificant residual fragments were observed in only one (4.8%). The procedure failed in two (9.5%) patients. A total of two minor complications (renal colic necessitating stent insertion and urinary tract infection) were observed postoperatively, none severe. Conclusion: Microperc is a feasible and efficient treatment modality for symptomatic LP calculi. Our results provide that microperc might take a part in case of SWL and RIRS failures or as an alternative to percutaneous nephrolithotomy or RIRS in the management of symptomatic LP calculi.

13 February 2014 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
ATAbdulkadir Tepeler
Abdulkadir Tepeler
TATolga Akman
Tolga Akman
MSMesrur Selcuk Silay
Mesrur Selcuk Silay
MAMuzaffer Akcay
Muzaffer Akcay
CECevper Ersoz
Cevper Ersoz
KSKemal Sarica
Kemal Sarica

1 February 2013 in Journal of Endourology
Verified
Journal Article
Closed access
AAAbdullah Armagan
Abdullah Armagan
ATAbdulkadir Tepeler
Abdulkadir Tepeler
MSMesrur Selcuk Silay
Mesrur Selcuk Silay
CECevper Ersoz
Cevper Ersoz
MAMuzaffer Akcay
Muzaffer Akcay
SOSinasi Yavuz Onol
Sinasi Yavuz Onol
Purpose: We present our initial experience with microperc in patients with moderate-size renal calculi. Patients and Methods: A retrospective analysis of 30 patients (male 14, female 16) with moderate-size (1–3 cm) kidney stones who underwent microperc between August 2011 and July 2012 was performed. The demographic values, perioperative and postoperative measures including age, stone size and location, body mass index, operative and fluoroscopy time, hemoglobin decrease, success and complication rates were prospectively recorded into a patient entry system. Results: The average stone size was 17.9±5.0 mm (10–30 mm). The mean age of the patients was 41.5±18.2 years (range 3–69 years). The duration of the operation was calculated as 63.5±36.8 minutes (range 20–200 min). Mean fluoroscopic screening time was 150.5±90.4 seconds (range 45–360 seconds). The patients were discharged after a mean hospitalization period of 35.5±18.6 hours (range 14–96 hours). An overall success rate of 93% (including 10% of insignificant residual fragment rate) was achieved. In the follow-up, residual stone fragments were detected in two (7%) patients. Conversion to miniperc was necessitated in three (10%) patients. The mean hemoglobin drop was found to be 1.1±0.8 mg/dL (range 0–2.8 mg/dL). Complications were observed in five (13.3%) patients. Conclusions: Our initial results provide that microperc is a feasible, safe, and efficacious treatment modality for moderate-size kidney stones as well as small ones with its minimally invasive nature. Technical refinements are needed to achieve better results and overcome the limitations of technique.

1 July 2012 in Journal of Endourology
Verified
Journal Article
Closed access
ATAbdulkadir Tepeler
Abdulkadir Tepeler
AAAbdullah Armağan
Abdullah Armağan
TATolga Akman
Tolga Akman
EPEmre Can Polat
Emre Can Polat
CECevper Ersöz
Cevper Ersöz
ŞÖŞinasi Yavuz Önol
Şinasi Yavuz Önol
Background and Purpose: Percutaneous nephrolithotomy (PCNL) is regarded as the gold standard for the treatment of patients with renal stones larger than 2 cm in diameter. Creating a percutaneous renal access is the initial and probably the most important step in performing a PCNL. Two primary methods of obtaining proper percutaneous renal access under fluoroscopic guidance are described: The “triangulation” and the “eye of the needle” techniques. In this article, we compare these two techniques in terms of success and complication rates. Patients and Methods: From October 2010 to May 2011, 80 patients with simple renal stones were prospectively randomized into two groups according to the percutaneous renal access technique used for PCNL. Patients in group 1 (n=40) were assigned to the eye of the needle technique, and patients in group 2 (n=40) were assigned to the triangulation method. Patients needing multiple access points were excluded from the study. The preoperative, operative, and postoperative follow-up findings were thereafter analyzed and compared. Results: No significant difference between the two groups was detected in terms of patient demographics (mean patient age, body mass index, stone size, or stone location). The operation time, fluoroscopic screening time (FST), and duration of hospitalization were similar in both groups (P=0.52, P=0.32, P=0.26, respectively). Patients in group 1 had a larger drop in hematocrit postoperatively than patients in group 2 (7.6±3.7 vs 4.8±2.1, P=0.001). The blood transfusion rate (7.5%) was similar in both groups, however. Although the complication rate was higher in group 1 than group 2, no significant difference was detected (20% vs 15%, P=0.76). Conclusions: The present study demonstrates that PCNL can be performed safely using two different percutaneous access techniques. The two techniques studied in this trial had similar FSTs, operation and hospitalization times, success rates, and complication rates.


1 February 2020 in International braz j urol
Verified
Journal Article
Open access
PDF file
AIAbdullah Ilktac
Abdullah Ilktac
BDBayram Dogan
Bayram Dogan
CECevper Ersoz
Cevper Ersoz
MAMuzaffer Akcay
Muzaffer Akcay
HAHabib Akbulut
Habib Akbulut
To assess the relationship between testicular germ cell tumors (TGCT) and neutrophil to lymphocyte ratio (NLR) and to determine whether this ratio can be used as a serum tumor marker. Sixty-one patients with testicular germ cell tumors were included into the study. Patients were grouped as localized and non-localized. Histologically patients were categorized as seminoma and nonseminomatous germ cell tumors. Complete blood cell count was measured the day before surgery and at the postoperative 1st month. Preoperative and postoperative mean NLR values were compared. Thirty-six patients (59%) had seminomas and 25 patients (41%) had nonseminomatous testicular cancer. Forty-five patients (73.8%) had localized and 16 patients (26.2%) had non-localized testicular cancer. There was a statistically significant difference between preoperative and postoperative mean NLR of the localized patients (p=0.001) but no such difference was detected for non-localized patients (p=0.576). Nineteen patients with localized seminomas had normal preoperative serum tumor markers. There was a significant difference between preoperative and postoperative mean NLR in this group of patients (p=0.010). Twenty-six patients with localized tumors had preoperative increased serum tumor markers which normalized after orchiectomy. Mean NLR of these patients significantly decreased from 3.10 ± 2.13 to 1.62 ± 0.59 postoperatively (p=0.010). NLR appears to be a useful marker for TGCT. It is successful in predicting localized and non-localized disease in early postoperative period.